Biogen: Biogen Must Face Investors' Claim on Alzheimer's Drug Trial Data
Biogen Inc. investors can advance their claim that the company misrepresented clinical trial data for its Alzheimer's drug, a federal judge ruled.
Read full article »
Biogen is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe.
Read more